|Articles|April 21, 2015
Dr. Primo Lara Discusses Emerging Therapies in Kidney Cancer
Primo Neary Lara Jr., associate director of Translational Research at the UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.
Advertisement
Primo Neary Lara Jr., associate director of Translational Research and co-leader of the Cancer Therapeutics Program at UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Advisory Committee Backs RP1 for Advanced Melanoma
2
Living With Lung Cancer, Not Dying From It: One Survivor's Story of Hope
3
Same-Day Discharge and Single-Incision Surgery Are Changing Rectal Cancer Care
4
Oncology Researcher Brings Science, Compassion and Personal Loss to Cancer Care
5